Abstract
Objective
Paget’s disease is an uncommon breast malignancy and often misdiagnosed. If the patient is treated at an early stage, the prognosis is satisfactory. Our study analyzed the clinical characteristics of the disease and the factors influencing the prognosis.
Methods
Fourty-five patients with Paget’s disease who were admitted to our hospital were analyzed retrospectively.
Results
The most common symptoms of the disease were erosion and a bleeding-like eczematoid change at the nipple/areola. Of the 40 patients with an eczematoid change, 11 patients had verified Paget’s disease with a palpable mass on physical examination, and 29 patients had verified Paget’s disease with a nonpalpable mass. Only 5 patients manifested a mass with no eczematiod change. Thirteen patients had ipsilateral axillary lymphadenopathy. In this study, 25 cases were treated by radical mastectomy and 20 cases were treated by modified radical mastectomy. Five and 10-year survival rates for the patients with nonpalpable masses and for those with palpable masses were 95.5%, 78.6%, and 53.8%, 36.4% respectively. The former were significantly higher than the latter (P <0.01 and <0.05 respectively). Five and 10-year survival rates for the patients without underlying carcinoma (DCIS/IDC) and for the patients with underlying carcinoma were 100%, 88.9% and 69.6%, 43.8% respectively. The former were significantly higher than the latter ( P<0.05) Five and 10-year survival rates for the patients with negative lymph nodes and for the patients with positive lymph nodes were 92.0%, 76.5% and 50.0%, 25.0% respectively. The former were also significantly higher than the latter (P<0.05).
Conclusion
Treatment at an early stage is very important and influences the prognosis directly for Paget’s disease of the breast. The survival rates of patients with nonpalpable masses without underlying carcinoma and without lymphadenopathy, were significantly higher than patients with palpable masses with underlying carcinoma and with lymphadenopathy respectively. There was significant statistical difference between each of the 2 groups.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dixon AR, Galca MH, Ellis IO, et al. Paget’s disease of the nipple. Br J Surg. 1991; 78: 722–723.
Sheen-Chen SM. Chen HS, Chen WJ, et al. Paget’s disease of the breastan easily overlooked disease? J Surg Oncol. 2001; 76: 261–265.
Fu W, Mittel VK, Young SC. Paget’s disease of the breast: Analysis of 41 patients. Am J Clin Oncol. 2001; 24: 397–400.
Lloydl J, Flanagaan AM. Mammary and extramammary Paget’s disease. J Clin Pathol. 2000; 53: 742–749.
Vielh P, Validire P, Kheirallah S, et al. Paget’s disease of the nipple without clinical and radiological detectable breast tumor: Histological and immunohistochemical study of 44 cases. Pathol Res Pract. 1993; 189:150–155.
Potter CR, Eeckhout L, Schelhout AM, et al. Keratinocyte induced chemotaxis in the pathogenesis of Paget’s disease of the breast. Histopathology. 1994; 24: 349–356.
Fu W, Lobock CA, Siberberg BK, et al. Molecular markers in Paget’s disease of the breast. J Surg Oncol. 2001; 77: 171–178.
Bijker N, Rutgers EJ, Duchateau L, et al. Breast-conserving therapy for Paget disease of the nipple: A prospective European Organization for Research and Treatment of Cancer Study of 61 Patients. Cancer. 2001; 91: 472–477.
Marshall JK, Griffith KA, Haffty BG, et al. Conservative management of Paget disease of the breast with radiotherapy. Cancer. 2003; 97: 2142–2149.
Kothari AS, Beechey-Mewman N, Hamed H, et al. Paget disease of the nipple. Cancer. 2002; 95: 1–7.
Author information
Authors and Affiliations
About this article
Cite this article
Yang, M., Long, H., He, J. et al. Paget’s disease of the breast: Clinical analysis of 45 patients. Chin. J. Clin. Oncol. 1, 236–240 (2004). https://doi.org/10.1007/BF02739807
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02739807